Health Advances

The latest edition of our Sharp Strategy Spotlight is now live! Read it here⬇️

The “boring” parts of healthcare are often the most important – Supply Chain Management platforms are no exception. Highlighted by the recent merger of Curvo and BroadJump, health systems’ investment in new tools and processes to manage the value and predictability of their supply chain is at an all-time high. Larger scale data and risk providers like GHX and symplr continue to integrate past investments, while #GPOs (like newly-private Premier Inc.) are focusing on supply chain as a natural adjacency to their core business. #HealthIT #SupplyChainManagement #GRC

Orthopedics in 2026 Over the past two years, the orthopedics market has been anything but calm. Leading strategics have made bold moves to reshape their portfolios underscoring a clear reality: OEMs are pruning low-margin, slower-growth segments and searching for areas that offer stability and upside. So where are those safe harbors? Well, we are already seeing glimpses of them in the wave of new innovations, partnerships, and acquisitions at the end of 2025 / beginning of 2026: -> Novel Manufacturing: Curiteva, Inc.’s recent launch of their 3D printed peek standalone ALIF system  (announced 2026), 3D Systems Corporation's recent approval for adolescent patient-specific implant printing (late 2025) -> Novel Biomaterials: TYBR Health's first clinical use cases with their anti-adhesion B3 GEL System (2026), ATEC Spine’s recent partnership for Theradaptive’s OsteoAdapt bone graft (announced 2026) -> Enabling Tech: See All AI, a potential disruptor transforming fluoroscopic X-rays into  CT-like 3D models, announced themselves fully at NASS (late 2025), LEM Surgical AG’s first US cases with their multi-arm, multi-procedure spine robot (late 2025), Highridge Medical’s partnership to distribute PathKeeper navigation (late 2025) -> Digital Solutions: Zimmer Biomet’s recent partnership with PatientIQ to integrate Zimmer’s mymobility and ZBEdge data with PatientIQ’s PRO data AND facility EHRs where PatientIQ is today (2026) -> MIS: Arthrex performs first case with their Nano arthroscopy platform (late 2025), meduloc’s joint-preserving intramedullary nail (approved late 2025) Beyond technology, certain procedure categories will continue to prove resilient given their underlying growth: -> Shoulder reconstruction: Johnson & Johnson MedTech’s INHANCE total shoulder solution (launched late 2025) -> Foot and ankle: Zimmer Biomet continues to roll out new implants from their Paragon28 acquisition -> Sports medicine: Smith+Nephew & Nephew’s recent acquisition of Integrity Orthopaedics for up to $450MM (announced 2026) -> Even spine, especially in novel categories like orthobiologic BMP/growth factors and synthetics, offer targeted opportunities where evidence is driving strong growth In a world of portfolio turbulence, the surest harbors pair innovation with procedural growth. For strategics and investors, the question isn’t whether to pivot, but how quickly you can align with these currents. With a plethora of dry power to invest in the market, 2026 is shaping up to be a landmark year for orthopedic innovation and activity. Where are you placing your bets?

Our first Sharp Strategy Spotlight of 2026 is now live! Read it here ⬇️

As we kick off the new year and look ahead to #JPM2026, leaders across our Diagnostics, Precision Medicine, Life Science Tools & Services, and Biopharma sectors have compiled their top highlights from 2025 along with key predictions for 2026. Meet with our leaders at JPM next week to discuss these trends and strategies to position your team for success.   Vivek Mittal, Donna Hochberg, Balazs Felcsuti, Michael Davitian, Arushi Agarwal, Daniela Hristova-Neeley, Patrick Symmonds, Laura Ory   #Biopharma #Diagnostcs #LST #PharmaServices #PrecisionMedicine 

Season’s Greetings from Health Advances! As we wrap up 2025, we’re grateful for the partnerships, progress, and shared successes that made this year extraordinary. Wishing you and your loved one's joy, peace, and a bright start to 2026. Cheers to new opportunities and continued collaboration in the year ahead.

Biotechs today are operating under tighter funding horizons and milestone‑driven pressure points where speed is critical. Accelerating clinical development requires more than operational efficiency; it demands strategic choices that de‑risk development while preserving scientific and regulatory integrity. Don’t miss Health Advances Partner & Managing Director Vivek Mittal and Parexel’s Jim Anthony as they discuss trends that will redefine clinical development over the next 3–5 years in an engaging fireside chat. See the details below or reach out to connect with Vivek. #BiotechShowcase #JPMweek #Biopharma #Biotech

The latest edition of our Sharp Strategy Spotlight is now live! Read it here⬇️

Health Advances' Biopharma, Diagnostics, Precision Medicine, and Life Science Tools & Services leaders will be in San Francisco for the JP Morgan Healthcare Conference January 12-15. Reach out to connect during #JPM2026.   Vivek Mittal, Donna Hochberg, Balazs Felcsuti, Michael Davitian, Arushi Agarwal, Daniela Hristova-Neeley, Patrick Symmonds, Laura Ory

Technology adoption in #SeniorLiving, #SkilledNursing, and #PostAcuteCare has historically lagged behind other healthcare sectors—often due to limited budgets and fewer incentives to implement #EHR systems. Yet, as these organizations face tighter margins and increasingly complex patient needs, innovation is accelerating—similar to what we saw in the pre-#MeaningfulUse era within #Medicaid and #FQHC markets. Today, leading companies such as PointClickCare, MatrixCare, and Aline are driving a wave of transformation, supported by a growing ecosystem of innovators. With the influx of #BabyBoomer patients and residents, the urgency for advanced solutions has never been greater. Emerging players like Yardi, ECP, Eldermark, Netsmart, Teton, Inspiren, Sensi.AI, Cairns Health, and Together by Renee are pushing boundaries in #HealthIT, #MemoryCare, and #PostAcuteSoftware, and we’re excited to see what’s next. Interested in Senior Living technology trends? Talk to our expert, Partner and Managing Director Greg Chittim.